Matches in Wikidata for { <http://www.wikidata.org/entity/Q73181361> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- Q73181361 description "article scientifique publié en 1999" @default.
- Q73181361 description "artículu científicu espublizáu n'abril de 1999" @default.
- Q73181361 description "im April 1999 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73181361 description "scientific article published on 01 April 1999" @default.
- Q73181361 description "wetenschappelijk artikel" @default.
- Q73181361 description "наукова стаття, опублікована у квітні 1999" @default.
- Q73181361 name "Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: A potential interest for predicting 5-FU toxicity and determining optimal 5-FU dosa" @default.
- Q73181361 name "Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: A potential interest for predicting 5-FU toxicity and determining optimal 5-FU dosa" @default.
- Q73181361 type Item @default.
- Q73181361 label "Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: A potential interest for predicting 5-FU toxicity and determining optimal 5-FU dosa" @default.
- Q73181361 label "Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: A potential interest for predicting 5-FU toxicity and determining optimal 5-FU dosa" @default.
- Q73181361 prefLabel "Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: A potential interest for predicting 5-FU toxicity and determining optimal 5-FU dosa" @default.
- Q73181361 prefLabel "Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: A potential interest for predicting 5-FU toxicity and determining optimal 5-FU dosa" @default.
- Q73181361 P1433 Q73181361-6CC307D5-31FE-4802-B72D-BD80D8E4C691 @default.
- Q73181361 P1476 Q73181361-BE6C0D9B-C13B-4587-A1C1-3806D4B34E6C @default.
- Q73181361 P2093 Q73181361-09DD20B8-9FA8-4CE3-B506-03AE81BD6DF0 @default.
- Q73181361 P2093 Q73181361-2BD60C43-C49B-4C9E-BD6C-6C5BA249AD97 @default.
- Q73181361 P2093 Q73181361-3CE0FD9D-FE3E-4591-BDDA-A3A423382B41 @default.
- Q73181361 P2093 Q73181361-3DAEAB51-34A3-4817-95D9-33C343A215F5 @default.
- Q73181361 P2093 Q73181361-8C33C736-94E1-4608-8DF6-4349C8A0172B @default.
- Q73181361 P2093 Q73181361-97E9B7A5-B25B-413F-BB19-75D3235F2ED9 @default.
- Q73181361 P2093 Q73181361-9B10E466-5559-4390-8239-D0ADDCAAFA84 @default.
- Q73181361 P2093 Q73181361-E6A05CB6-F543-4FC3-9137-DA2BEACF2E27 @default.
- Q73181361 P304 Q73181361-F5E76510-D3F2-48BF-8FE1-896A268DE1E9 @default.
- Q73181361 P31 Q73181361-8B9567DD-D05C-48BD-BEDA-28CF93A3BDE1 @default.
- Q73181361 P356 Q73181361-EA061A88-4927-455E-BDFC-3028BB846FD0 @default.
- Q73181361 P407 Q73181361-16F1085A-9E27-497A-9C6C-E0925DE12D87 @default.
- Q73181361 P433 Q73181361-F0D78255-4C42-4939-94C5-71FFB26B0915 @default.
- Q73181361 P478 Q73181361-AD04E616-C204-4631-8880-42C4310BE053 @default.
- Q73181361 P50 Q73181361-03E2E0D6-5A8A-4526-9A7F-73F13518F6D5 @default.
- Q73181361 P577 Q73181361-BB500D3A-C19A-44CA-B8BC-AA5550CE113A @default.
- Q73181361 P698 Q73181361-407D8866-775D-4514-8FE2-FF216941E0B2 @default.
- Q73181361 P921 Q73181361-0432B3D9-0AF3-4984-B808-B9954A4D9C18 @default.
- Q73181361 P921 Q73181361-075393A7-21AA-421B-8635-0D30F22A1205 @default.
- Q73181361 P921 Q73181361-A0ADFE09-F1BD-40A2-9BF5-AA22D766C99A @default.
- Q73181361 P921 Q73181361-A28281B5-4635-44C4-A1D2-E9DC091CBE67 @default.
- Q73181361 P356 JCO.1999.17.4.1105 @default.
- Q73181361 P698 10561167 @default.
- Q73181361 P1433 Q400292 @default.
- Q73181361 P1476 "Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: A potential interest for predicting 5-FU toxicity and determining optimal 5-FU dosage" @default.
- Q73181361 P2093 "A Lortholary" @default.
- Q73181361 P2093 "E Gamelin" @default.
- Q73181361 P2093 "F Genevieve" @default.
- Q73181361 P2093 "F Larra" @default.
- Q73181361 P2093 "J Robert" @default.
- Q73181361 P2093 "M Boisdron-Celle" @default.
- Q73181361 P2093 "R Delva" @default.
- Q73181361 P2093 "V Guérin-Meyer" @default.
- Q73181361 P304 "1105" @default.
- Q73181361 P31 Q13442814 @default.
- Q73181361 P356 "10.1200/JCO.1999.17.4.1105" @default.
- Q73181361 P407 Q1860 @default.
- Q73181361 P433 "4" @default.
- Q73181361 P478 "17" @default.
- Q73181361 P50 Q56549745 @default.
- Q73181361 P577 "1999-04-01T00:00:00Z" @default.
- Q73181361 P698 "10561167" @default.
- Q73181361 P921 Q188874 @default.
- Q73181361 P921 Q238512 @default.
- Q73181361 P921 Q25493920 @default.
- Q73181361 P921 Q323936 @default.